Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Ferracin

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
Glycobiology|July 19, 2019
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell typesGiulia Venturi, Inês Gomes Ferreira, Michela Pucci, et al.
Epilepsia Open|May 12, 2018
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies?Paolo Roncon, Silvia Zucchini, Manuela Ferracin, et al.
Frontiers in Oncology|November 16, 2020
The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-AnalysisCecilia Pop-Bica, Sebastian Pintea, Lorand Magdo, et al.
Free Radical Biology & Medicine|November 22, 2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Manuela Ferracin, Silvia Sabbioni, et al.
Molecular Medicine (Cambridge, Mass.)|April 26, 2013
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeAntonella Chillemi, Gianluca Zaccarello, Valeria Quarona, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
MicroRNAs dysregulation in human malignant pleural mesotheliomaVeronica Balatti, Stefania Maniero, Manuela Ferracin, et al.
Journal of Clinical Medicine|February 26, 2025
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal CancersDaria Maria Filippini, Elisabetta Broseghini, Carlotta Liberale, et al.
Expert Review of Molecular Diagnostics|March 2, 2022
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancerGiorgio Durante, Elisabetta Broseghini, Francesca Comito, et al.
Pathology, Research and Practice|May 20, 2022
Dysplastic nevi and melanoma: microRNAs tell a divergent storyGiorgio Durante, Giulia Veronesi, Cosimo Misciali, et al.
Italian Journal of Dermatology and Venereology|March 30, 2020
Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaicEmi Dika, Annalisa Patrizi, Cesare Rossi, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Glycobiology|July 19, 2019
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell typesGiulia Venturi, Inês Gomes Ferreira, Michela Pucci, et al.
Epilepsia Open|May 12, 2018
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies?Paolo Roncon, Silvia Zucchini, Manuela Ferracin, et al.
Frontiers in Oncology|November 16, 2020
The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-AnalysisCecilia Pop-Bica, Sebastian Pintea, Lorand Magdo, et al.
Free Radical Biology & Medicine|November 22, 2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Manuela Ferracin, Silvia Sabbioni, et al.
Molecular Medicine (Cambridge, Mass.)|April 26, 2013
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeAntonella Chillemi, Gianluca Zaccarello, Valeria Quarona, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
MicroRNAs dysregulation in human malignant pleural mesotheliomaVeronica Balatti, Stefania Maniero, Manuela Ferracin, et al.
Journal of Clinical Medicine|February 26, 2025
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal CancersDaria Maria Filippini, Elisabetta Broseghini, Carlotta Liberale, et al.
Expert Review of Molecular Diagnostics|March 2, 2022
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancerGiorgio Durante, Elisabetta Broseghini, Francesca Comito, et al.
Pathology, Research and Practice|May 20, 2022
Dysplastic nevi and melanoma: microRNAs tell a divergent storyGiorgio Durante, Giulia Veronesi, Cosimo Misciali, et al.
Italian Journal of Dermatology and Venereology|March 30, 2020
Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaicEmi Dika, Annalisa Patrizi, Cesare Rossi, et al.
Pageof 19